Recurrent Head and Neck Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00515Cisplatin1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB06176Romidepsin1Recruiting1
DB08916Afatinib2Recruiting1
DB00002Cetuximab2Active Not Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB11886Infigratinib2Not Yet Recruiting1
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting1
DB01268Sunitinib2Recruiting1
DB12200Tivantinib2Active Not Recruiting1
DB08911Trametinib2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB08828Vismodegib2Recruiting1